ライフサイエンスコーパス: tertiary referral center

1 tients referred to Oslo University Hospital (tertiary referral center).

2 May 1, 2010, through October 31, 2012, at a tertiary referral center.

3 e noncomparative analysis was conducted at a tertiary referral center.

4 tional cohort study was conducted in a Dutch tertiary referral center.

5 pectively evaluated by a single surgeon at a tertiary referral center.

6 valuating a new technique was conducted at a tertiary referral center.

7 ugh retrospective medical record review at a tertiary referral center.

8 nterventional case series was conducted at a tertiary referral center.

9 ith history of microbial keratitis seen at a tertiary referral center.

10 e consecutive case series was conducted at a tertiary referral center.

11 for 19 children with cataract operated at a tertiary referral center.

12 ed cirrhosis, confirmed by histology, from a tertiary referral center.

13 in a hypertrophic cardiomyopathy cohort at a tertiary referral center.

14 The authors are from a pediatric tertiary referral center.

15 r inflammatory disease in a university-based tertiary referral center.

16 were diagnosed with posterior scleritis in a tertiary referral center.

17 raction maculopathy by a single surgeon at a tertiary referral center.

18 roidectomy and routine prophylactic CND at a tertiary referral center.

19 period (January 1999 to December 2000) at a tertiary referral center.

20 ypertrophic cardiomyopathy (HCM) seen at our tertiary referral center.

21 th 82 VCFs who underwent vertebroplasty at a tertiary referral center.

22 ween 1996 and 2001 who were followed up in a tertiary referral center.

23 98 lesions in 7147 consecutive patients at a tertiary referral center.

24 from a multidisciplinary dyspnea clinic at a tertiary referral center.

25 went percutaneous coronary intervention in a tertiary referral center.

26 eye, 5%) assisted by the SPOT technique in a tertiary referral center.

27 l procedures done between 2013 and 2023 at a tertiary referral center.

28 patients with unexplained heart failure at a tertiary referral center.

29 ients (63 eyes) with ARN treated in a single tertiary referral center.

30 anuary 2021 at Cleveland Clinic Abu Dhabi, a tertiary referral center.

31 onducted between May 2017 and June 2021 at a tertiary referral center.

32 from 2018 through 2020 in a NET program at a tertiary referral center.

33 18, 2019, and December 31, 2023, at a single tertiary referral center.

34 study was performed in a single-institution, tertiary referral center.

35 study on consecutive CSC patients seen at a tertiary referral center.

36 Of those, 11 (46%) worked at an academic or tertiary referral center.

37 a cross-sectional study at a single academic tertiary referral center.

38 with ABCA4 retinopathy were recruited from a tertiary referral center.

39 reduction therapy (SRT) during 20 years in a tertiary referral center.

40 e review of E-PPV between 2017 and 2021 at a tertiary referral center.

41 E6B-associated retinal dystrophy in a single tertiary referral center.

42 diabetic retinopathy (DR) severity seen at a tertiary referral center.

43 ting to the echocardiography laboratory of a tertiary referral center.

44 tomography angiography (CCTA) in an Italian tertiary referral center.

45 oing digital SOVC between 2015 and 2019 at a tertiary referral center.

46 rospective pilot study performed at a single tertiary referral center.

47 ary 1, 2012 and June 30, 2014 in an academic tertiary referral center.

48 opathologic phenotypes at a university-based tertiary referral center.

49 membrane oxygenation from 2012 to 2018 at a tertiary referral center.

50 ndergoing cranial and spinal operations in a tertiary referral center.

51 pective case series at a single institution, tertiary referral center.

52 The study was performed in a tertiary referral center.

53 eated for primary open angle glaucoma in our tertiary referral center.

54 treated with 35 dexamethasone implants at a tertiary referral center.

55 om August 8, 2006, until June 17, 2015, at a tertiary referral center.

56 edian age, 52 years; range, 9-79 years) in a tertiary referral center.

57 at Memorial Sloan-Kettering Cancer Center, a tertiary referral center.

58 rience with MRE in pregnant CD patients in a tertiary referral center.

59 d 2012 with follow-up of 5 to 25 months at a tertiary referral center.

60 ith a GDD were retrospectively analyzed at 2 tertiary referral centers.

61 ervational multicenter cohort study among MS tertiary referral centers.

62 treated with RFA from 2003 through 2011 at 3 tertiary referral centers.

63 data from 9 patients (11 eyes) with AMN at 6 tertiary referral centers.

64 type 2) the outer plexiform layer (OPL) at 6 tertiary referral centers.

65 nosed with herpes virus infection, seen at 2 tertiary referral centers.

66 l data using current therapeutic regimens at tertiary referral centers.

67 ingly becoming the preferred option at major tertiary referral centers.

68 and increasingly becoming an option at major tertiary referral centers.

69 ts with ALF collected prospectively at 24 US tertiary referral centers.

70 larization for ACS through early transfer to tertiary referral centers.

71 ire specialized care that is offered only at tertiary referral centers.

72 2014 were identified from 2 databases from 2 tertiary referral centers.

73 s of up to 6%, based largely on reports from tertiary referral centers.

74 for more than 1 year from 2007 to 2020 in 2 tertiary referral centers.

75 lyzed data acquired from 2002 to 2019 from 9 tertiary referral centers.

76 o 2021 at the dermatology clinics of 2 major tertiary referral centers.

77 e recorded in prospective OAT databases at 2 tertiary referral centers.

78 (CFC) in XRLS patients in Dutch and Belgian tertiary referral centers.

79 with late gadolinium enhancement (LGE) at 2 tertiary referral centers.

80 able serum hepatitis B virus DNA in European tertiary referral centers.

81 nts with HCM without prior SCD event, from 2 tertiary referral centers.

82 d February 2015, in neurology departments at tertiary referral centers.

83 ients (N = 486) having curative surgery at a tertiary referral center (2002-2011) was conducted.

84 ter registry of patients with BAV treated at tertiary referral centers, 2118 patients with BAV were e

85 At 3 tertiary referral centers, 228 patients with non-ischemi

86 cohort of 500 eyes that underwent DMEK at a tertiary referral center, 7 eyes developed typical clini

87 cohort study was conducted at multicentered tertiary referral centers across Canada.

88 Interventional case series at a tertiary referral center among 16 patients.

89 subjects undergoing coronary angiography in tertiary referral centers (an initial discovery US Cohor

90 ightly assessments was performed at an urban tertiary referral center and a regional center from Janu

91 imaging taken in routine clinical care at a tertiary referral center and associated satellites betwe

92 dle ear disease and ET dysfunction seen at a tertiary referral center and scheduled for tympanoplasty

93 periences with vedolizumab at a large German tertiary referral center and to identify clinical predic

94 A combination of 17 tertiary referral centers and private practices worldwid

95 h noninfectious anterior scleritis seen at 2 tertiary referral centers and studied the factors associ

96 Massachusetts General Hospital (tertiary referral center) and two affiliated community h

97 tients with FD and gastroparesis, as seen in tertiary referral centers at least, are not distinguisha

98 ul DMEK for Fuchs endothelial dystrophy at a tertiary referral center, best spectacle-corrected visua

99 study of PWID aged >=18 years admitted to a tertiary referral center between 01/2016 and 07/2019, wh

100 or 63 eyes of 63 patients who presented to a tertiary referral center between 2006 and 2015 with cult

101 fecal microbiota transplantation (FMT) at a tertiary referral center between 2011 and 2014 to determ

102 ministrative data on 682,704 patients from a tertiary referral center between 2011 and 2015, and iden

103 juries treated with either RA-MAC or GA at a tertiary referral center between 2015 and 2020.

104 omized clinical trial took place at a single tertiary referral center between August 2019 and July 20

105 on (group 2: n = 100) for rectal cancer at a tertiary referral center between December 1998 and July

106 ndergone gender-affirming mastectomy at a US tertiary referral center between January 1, 1990, and Fe

107 nts undergoing abdominal surgery for CD at a tertiary referral center between January 1998 and June 2

108 m who underwent simultaneous AVS at a single tertiary referral center between January 2015 and Decemb

109 AO (ICD-10: H34.1) initially presenting to a tertiary referral center between January 2017 and Decemb

110 s or older diagnosed with breast cancer at a tertiary referral center between January and December 20

111 vanced Fuchs dystrophy at a university-based tertiary referral center between July 1, 2017, and Augus

112 derwent radical prostatectomy performed at a tertiary referral center between July 1998 and July 2003

113 ive patients undergoing genetic testing at a tertiary referral center between July 2005 and November

114 patients (n = 641) who underwent OLT at our tertiary referral center between March 1985 and December

115 ervical cancer patients who presented to our tertiary referral center between March 2011 and February

116 ren (aged <21 years) who were evaluated at a tertiary referral center between November 1, 1975, and J

117 Severely ill burn patients admitted to our tertiary referral center between October 2013 and Februa

118 y for ampullary adenocarcinoma in 9 European tertiary referral centers between February 2006 and Dece

119 double-blind clinical trial in 3 Australian tertiary referral centers between June 2013 and June 201

120 unit (ICU) of University Hospitals Leuven, a tertiary referral center, between 1 March 2020 and 14 No

121 less accurate when applied to populations in tertiary referral centers characterized by a high preval

122 retrospective chart review of patients at a tertiary referral center compares characteristics and cl

123 oing total or distal gastrectomy in 10 Dutch tertiary referral centers, cost-effectiveness data were

124 In two tertiary referral centers, donors undergoing left-sided

125 ients (52 eyes) who were treated at a single tertiary referral center during a 10-year period.

126 Patients receiving care at tertiary referral centers evaluated between 2012 and 201

127 pective cohort study at an academic hospital tertiary referral center evaluating the growth rate of h

128 udative retinal detachment (ERD) in a single tertiary referral center experience.

129 All patients seen at a dedicated tertiary referral center for a suspicion of vascular Ehl

130 largest hospital in the Middle East and the tertiary referral center for all hospitals in Egypt that

131 ow-up during 2015-2020 recruited at the only tertiary referral center for ALS in Stockholm, Sweden, a

132 l study conducted between 2011 and 2014 at a tertiary referral center for ALS.

133 ort study was conducted using records from a tertiary referral center for autoimmune bullous disorder

134 ules on photodamaged skin was conducted in a tertiary referral center for dermatology between January

135 cutive series of 76 patients presenting to a tertiary referral center for evaluation of chronic progr

136 nd followed up with a family presenting to a tertiary referral center for evaluation of HSP for a dec

137 Only 1% of unrelated individuals seen at a tertiary referral center for HCM possessed one of the fi

138 years sequentially referred to a midwestern tertiary referral center for hearing loss or cochlear im

139 ith CIS between March 2002 and May 2015 in a tertiary referral center for multiple sclerosis, in coll

140 Academic tertiary referral center for neurodegenerative disorders

141 bservational cohort study was conducted at a tertiary referral center for neurological diseases in Ri

142 skeletal and/or eye abnormalities, from a US tertiary referral center for neurological diseases using

143 rity cohort study performed at a high-volume tertiary referral center for parathyroidectomy with blin

144 We queried the medical records of a large tertiary referral center for patients with a history of

145 clinical trial with a 2-year follow-up at a tertiary referral center for pediatric obesity in the Ne

146 in the Netherlands, including the dedicated tertiary referral center for pediatric oncology care.

147 Medical Center, Nijmegen, the Netherlands, a tertiary referral center for retinal disorders.

148 012) prospective cohort study conducted in a tertiary referral center for the diagnosis and follow-up

149 a large urban catchment area and serves as a tertiary referral center for the province of Ontario).

150 en January 2016 and July 2023 at an academic tertiary referral center for thyroid surgery.

151 Eyes with uveitis seen at a single tertiary referral center for which ME was the principal

152 ction strategies was conducted in 3 European tertiary referral centers for HCM from July 2013 to Dece

153 nrolled patients with PBC (n = 1032) from 23 tertiary referral centers for liver diseases in the Unit

154 rvational study, 2 groups of patients from 2 tertiary referral centers for melanoma (Sydney Melanoma

155 lticenter study was conducted (1992-2010) in tertiary referral centers for treatment of cutaneous mel

156 erve palsies in children, but a study from a tertiary referral center found a high incidence of neopl

157 M (unweighted sample n = 155) performed at a tertiary referral center from 09/2015-03/2017 yielded a

158 nts older than 10 years with ROP seen at our tertiary referral center from 2000 through 2018, 5 (3.6%

159 Patients diagnosed with ARN at a tertiary referral center from 2010 to 2020.

160 sis used data from the satellite office of a tertiary referral center from August 2, 2013, to April 9

161 ective cohort of patients at a single-center tertiary referral center from January 1, 1998, to Octobe

162 d subsequently undergoing patch testing at a tertiary referral center from January 1, 2012, through N

163 l endophthalmitis isolates in specimens at a tertiary referral center from January 1996 to April 2019

164 who were admitted for any cause at a single tertiary referral center from January 2013 to May 2024.

165 ing pancreatic surgery at a university-based tertiary referral center from July 1, 2013, through June

166 cription (control) was conducted at a single tertiary referral center from June 1 to December 30, 202

167 Prospective cross-sectional study at a tertiary referral center from March 1, 2012, to January

168 months scheduled for cardiac surgery at our tertiary referral center from March 2018 to July 2019 we

169 label cohort study was conducted at a single tertiary referral center from September 6, 2019, to Sept

170 orders who received ipilimumab at 9 academic tertiary referral centers from January 1, 2012, through

171 Hershey Medical Center, an academic tertiary referral center, from May 1, 2011, through Nove

172 istry between October 1985 and May 2014 at a tertiary referral center hosting the Dutch Cutaneous Lym

173 ods: The institutional databases of 3 German tertiary referral centers identified 106 patients who un

174 versity Hospital Foundation Trust [CUHFT], a tertiary referral center in Cambridge, England.

175 y 28, 2021, at the emergency department of a tertiary referral center in central Israel.

176 stitute of Medical Education and Research, a tertiary referral center in Chandigarh, India.

177 clinical trial took place at a single-center tertiary referral center in Charleston, South Carolina.

178 , and October 31, 2021, at a single academic tertiary referral center in Durham, North Carolina.

179 gle-center trial was conducted in a neonatal tertiary referral center in Germany.

180 to 17% of HBeAg-negative patients seen in a tertiary referral center in Hong Kong.

181 uring and after the lockdown early 2020 in a tertiary referral center in Kiel, Germany.

182 the demographic and clinical data of EC in a tertiary referral center in Lebanon and to determine the

183 rs of treatment with DFO were recruited in a tertiary referral center in Milan, Italy, and were inves

184 ive patients who presented with uveitis at a tertiary referral center in northern Taiwan between Augu

185 ulfilled the diagnostic criteria for NS in a tertiary referral center in Paris, France, from January

186 edical practices affiliated with an academic tertiary referral center in Pennsylvania.

187 pediatric blepharokeratoconjunctivitis at a tertiary referral center in Singapore from 1991 through

188 Patients were from a single academic-based tertiary referral center in Switzerland.

189 This clinic-based cohort from a tertiary referral center in Taiwan included 1229 patient

190 study of a national US population based at a tertiary referral center in the San Francisco Bay Area u

191 hcet disease and 445 matched controls from a tertiary referral center in the U.K.

192 s and test results from patients attending a tertiary referral center in the UK.

193 17 patients 6 years and older at baseline at tertiary referral centers in Europe, the United States,

194 l 30, 2022, at the emergency department of 3 tertiary referral centers in France.

195 tive collection of real-world data from five tertiary referral centers in Germany was conducted, enro

196 from January 2007 through February 2020 in 2 tertiary referral centers in Germany.

197 18 years) patients with CD from 13 pediatric tertiary referral centers in Italy.

198 phonic amplitude of 5 muV or higher across 3 tertiary referral centers in Melbourne, Australia; Bern,

199 alysis was conducted on patients seen at two tertiary referral centers in Mexico.

200 012 to November 2021 at 2 academic pediatric tertiary referral centers in Oregon.

201 -13 years; 67% male) were identified from 10 tertiary referral centers in the Netherlands and Belgium

202 rospective case series of 21 patients from 5 tertiary referral centers in the United Kingdom and Aust

203 retrospective cohort study was conducted at tertiary referral centers in the United States and Europ

204 l-level primary data were accumulated from 6 tertiary referral centers in the United States, Belgium,

205 h MASLD who underwent VCTE examination at 16 tertiary referral centers in the US, Europe, and Asia fr

206 A retrospective case series in a tertiary referral center included 100 consecutive patien

207 mized clinical study carried out in a single tertiary referral center included 2 groups of 30 patient

208 nterventional cohort analysis performed at a tertiary referral center included 43 laser-naive patient

209 ross-sectional study at a single-center at a tertiary referral center included patients with a histor

210 ed a 1-year randomized controlled trial at a tertiary referral center, including 263 adults (178 with

211 these results were similar to those of other tertiary referral centers, it would be reasonable to per

212 cysts) from patients undergoing surgery at 4 tertiary referral centers (January 2010 through June 201

213 PACS patients encountered at tertiary referral centers may represent more advanced ca

214 tic HFpEF and chronotropic incompetence at a tertiary referral center (Mayo Clinic) in Rochester, Min

215 Italian tertiary referral center medical-surgical ICU.

216 Descriptive, noncomparative case series at a tertiary referral center (Ocular Oncology Service of Wil

217 is is a retrospective analysis from a single tertiary referral center of all patients older than 18 y

218 Retrospective review at a university tertiary referral center of all pregnant patients seen w

219 neas and keratoplasty recipients at a single tertiary referral center over 20 years.

220 es from 55 autopsies examined at an academic tertiary referral center over 21 years were tabulated fo

221 Thirty-six French MS tertiary referral centers participated.

222 At a single tertiary referral center, patients with HCC were randoml

223 rom February 7, 2014, to July 15, 2015, in a tertiary referral center pediatric dermatology clinic an

224 d their associated phenotype(s) from a large tertiary referral center population are unknown.

225 challenging and currently performed only in tertiary referral centers, represents the bottleneck in

226 f patients with granulomatous cheilitis at a tertiary referral center seeks to better describe the de

227 University of Pennsylvania Health System, a tertiary referral center serving a population with a hig

228 omies with additional wedge resections, at a tertiary referral center specialized in laparoscopic hep

229 cava filters on the basis of results from a tertiary referral center specializing in complex filter

230 18, 2018, and January 15, 2024, at a single tertiary referral center specializing in HCM care.

231 These data, from an ocular tertiary referral center, suggest that conjunctival tumo

232 risk of rupture may be safely undertaken at tertiary referral centers that have expertise in managin

233 rospectively maintained data from 27 Western tertiary referral centers: the population was divided in

234 The data were obtained from patients from 23 tertiary referral centers throughout the United States a

235 ections performed between 2004 and 2015 at 4 tertiary referral centers to identify pathologically con

236 ospective case series from a single academic tertiary referral center (University of Nebraska Medical

237 r cohort study was conducted at 4 Australian tertiary referral centers using prospectively collected

238 th GIB from January 2013 to August 2023 at a tertiary referral center was examined.

239 The treatment of pancreatic necrosis at a tertiary referral center was reviewed to effect better p

240 tained from 389 HCM outpatients seen at this tertiary referral center were analyzed for mutations, us

241 med between July 1985 and December 1991 in a tertiary referral center were analyzed.

242 een October 2014 and May 2016, patients at a tertiary referral center were included in the Oncologica

243 ations before uncomplicated triple DMEK at a tertiary referral center were included.

244 R inhibitors as cancer treatment at a single tertiary referral center were included.

245 undergoing transvenous lead extraction at a tertiary referral center were prospectively gathered fro

246 dectomy for primary hyperparathyroidism at a tertiary referral center were prospectively given a ques

247 first 100 adult patients treated in a single tertiary referral center were retrospectively identified

248 Patients undergoing ERC at our tertiary referral center were retrospectively included.

249 rophic cardiomyopathy from 2003 to 2019 at a tertiary referral center were reviewed retrospectively.

250 from 1967 through 2019 at a single academic, tertiary referral center were reviewed.

251 nts with traumatic macular holes at a single tertiary referral center were reviewed.

252 orts from 1/1/2000 to 12/31/2009 at a single tertiary referral center were reviewed; clinical informa

253 - 21.2 years; n = 35 female patients) from 6 tertiary referral centers were included.

254 and 85 patients with episcleritis seen at 2 tertiary referral centers were reviewed and their clinic

255 terdam Dementia Cohort (longitudinal cohort, tertiary referral center) were studied.

256 onoverlapping surgical procedures at a large tertiary-referral center where overlapping surgery is pe

257 y a board-certified dermatologist at a large tertiary referral center, where ENFD testing became a ro

258 y a board-certified dermatologist at a large tertiary referral center, where ENFD testing became a ro

259 rly-stage neoplasia should be centralized in tertiary referral centers, where procedures are performe

260 tients treated with osmotic BBBD at a single tertiary referral center who had subsequent ophthalmic e

261 ve review of 263 patients at a large, urban, tertiary referral center who underwent either dynamic pa

262 11, all patients with esophageal cancer in a tertiary referral center, who underwent nCRT (5 weekly c

263 patients with active TB SLC seen at a single tertiary referral center with 6 months follow-up after i

264 This study took place in a tertiary referral center with a cohort of 84 Finnish pat

265 Patients were included from a large US tertiary referral center with new severe TR by echocardi

266 This study involved 5 tertiary referral centers with a specialized adult conge

267 eyes) referred to Oslo University Hospital (tertiary referral center) with late in-the-bag IOL dislo

268 undergone genetic testing in 7 international tertiary referral centers worldwide were enrolled from M